Hyderabad, India, and Shenzhen, China (28 January 2013) - In a scientific breakthrough that promises improved grain yields and quality, greater drought tolerance and disease resistance, and enhanced genetic diversity, a global research team has completed high-quality sequencing of not one but ninety genomes of chickpea.
Nature Biotechnology, the highest ranked journal in the area of biotechnology, featured the reference genome of the CDC Frontier chickpea variety and genome sequence of 90 cultivated and wild genotypes from 10 different countries, as an online publication on 27 January 2013. The paper provides a map of the structure and functions of the genes that define the chickpea plant. It also reveals clues on how the sequence can be useful to crop improvement for sustainable and resilient food production toward improved livelihoods of smallholder farmers particularly in marginal environments of Asia and sub-Saharan Africa.
The research milestone was the result of years of genome analysis by the International Chickpea Genome Sequencing Consortium (ICGSC) led by the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) headquartered in Hyderabad, Andhra Pradesh India, involving 49 scientists from 23 organizations in 10 countries. ICRISAT is a member of the CGIAR Consortium.
The global research partnership succeeded in identifying an estimated 28,269 genes of chickpea after sequencing CDC Frontier, a kabuli (large-seeded) chickpea variety. Re-sequencing of additional 90 genotypes provided millions of genetic markers and low diversity genome regions that may be used in the development of superior varieties with enhanced drought tolerance and disease resistance. This will help chickpea farmers become more resilient to emerging challenges brought about by the threat of climate change. The genome map can also be used to harness genetic diversity by broadening the genetic base of cultivated chickpea genepool.
Chickpea is the second largest cultivated grain food legume in the world, grown in about 11.5 million hectares mostly by resource poor farmers in the semi-arid tropics. The highly nutritious, drought-tolerant chickpea contributes to income generation and improved livelihoods of smallholder farmers in African countries like Ethiopia, Tanzania and Kenya, and is crucial to the food security in India (being the largest producer, consumer and importer of the crop). Chickpea is also an important component of the pulse industry in Australia, Canada and USA.
"ICRISAT and its partners have once again demonstrated the power of productive partnerships by achieving this breakthrough in legume genomics," says Dr William Dar, Director General, ICRISAT. "Under the CGIAR Research Program (CRP) on Grain Legumes led by ICRISAT along with other CGIAR Consortium members and program as well as national partners, genome sequencing will play a crucial role in speeding up the development of improved varieties for smallholder farmer crops such as chickpea."
"In the face of the growing global hunger and poverty amid the threat of climate change, the chickpea genome sequence will facilitate the development of superior varieties that will generate more income and help extricate vulnerable dryland communities out of poverty and hunger for good, particularly those in the drylands of Asia and sub-Africa for whom ICRISAT and our partners are working," Dr Dar adds.
"Genetic diversity, an important prerequisite for crop improvement, is very limited and has been a serious constraint for chickpea improvement. This study will provide not only access to 'good genes' to speed up breeding, but also to genomic regions that will bring genetic diversity back from landraces or wild species to breeding lines," explains Dr Rajeev Varshney, coordinator of ICGSC and Director - Center of Excellence in Genomics, ICRISAT.
"At the moment, it takes 4-8 years to breed a new chickpea variety. This genome sequence could reduce to half the time to breed for a new variety with market-preferred traits." he adds.
According to Professor Jun Wang, Director of BGI, "The collaboration between BGI and ICRISAT has yielded significant achievements in orphan crops research, like the pigeonpea genome before and now, the chickpea genome. I believe that our partnership will revolutionize research on orphan crops, which are key staple crops in many low-income countries and are extremely important to smallholder farmers worldwide. The chickpea genome sequencing project was undertaken by the ICGSC led by ICRISAT, the University of California-Davis (USA) and BGI-Shenzhen (China) with key involvement of national partners in India, USA, Canada, Spain, Australia, Germany and Czech Republic.
The International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT), www.icrisat.org, is a non-profit, non-political organization that conducts agricultural research for development in Asia and sub-Saharan Africa with a wide array of partners throughout the world. Covering 6.5 million square kilometers of land in 55 countries, the semi-arid tropics have over 2 billion people, and 644 million of these are the poorest of the poor. ICRISAT and its partners help empower these poor people to overcome poverty, hunger and a degraded environment through better agriculture.
ICRISAT is headquartered in Patancheru near Hyderabad, Andhra Pradesh, India, with two regional hubs and five country offices in sub-Saharan Africa. It is a member of the CGIAR Consortium.
CGIAR is a global agriculture research partnership for a food secure future. Its science is carried out by 15 research Centers who are members of the CGIAR Consortium in collaboration with hundreds of partner organizations. www.cgiar.org
BGI was founded in Beijing, China, in 1999 with the mission to become a premier scientific partner for the global research community. The goal of BGI is to make leading-edge genomic science highly accessible, which it achieves through its investment in infrastructure, leveraging the best available technology, economies of scale, and expert bioinformatics resources. BGI, and its affiliates, BGI Americas, headquartered in Cambridge, MA, and BGI Europe, headquartered in Copenhagen, Denmark, have established partnerships and collaborations with leading academic and government research institutions as well as global biotechnology and pharmaceutical companies, supporting a variety of disease, agricultural, environmental, and related applications.
BGI has a proven track record of excellence, delivering results with high efficiency and accuracy for innovative, high-profile research: research that has generated over 200 publications in top-tier journals such as Nature and Science. BGI's many accomplishments include: sequencing one percent of the human genome for the International Human Genome Project, contributing 10 percent to the International Human HapMap Project, carrying out research to combat SARS and German deadly E. coli, playing a key role in the Sino-British Chicken Genome Project, and completing the sequence of the rice genome, the silkworm genome, the first Asian diploid genome, the potato genome, and, more recently, have sequenced the human Gut Metagenome, and a significant proportion of the genomes for the1000 Genomes Project.
For more information about BGI, please visit www.genomics.cn.
Coordinator of ICGSC and Director - Center of Excellence in Genomics, ICRISAT
Public Communication Officer